CVS Investors Can Join Fraud Lawsuit

NEW YORK, Aug. 9, 2024 — Rosen Law Firm, a prominent global investor rights law firm, has issued a reminder to investors who purchased securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023, and April 30, 2024. The firm highlights an important deadline of September 10, 2024, for potential lead plaintiffs to join a class action lawsuit against the company. Investors who acquired CVS securities during the specified period may be eligible for compensation without incurring any out-of-pocket fees, thanks to a contingency fee arrangement. Interested parties can join the class action by visiting the Rosen Law Firm's website or contacting attorney Phillip Kim for further information. Those wishing to serve as lead plaintiffs must file their motions by the September deadline. The lawsuit alleges that CVS made several misleading statements and failed to disclose critical information regarding its financial forecasts. Specifically, it claims that the company’s projections for plan premiums did not adequately account for rising medical costs and healthcare utilization, leading to significant unanticipated expenses. Consequently, CVS is accused of overstating the profitability of its Health Care Benefits segment and misrepresenting the financial health of its other business segments. As of now, no class has been certified, meaning that investors are not represented by counsel unless they choose to retain one. The Rosen Law Firm encourages affected investors to take action promptly to protect their rights.